title: Editorial: Medication-related osteonecrosis of the jaw (MRONJ): Bisphosphonates, antiresorptives, and antiangiogenic agents. What next?
authors.forename: Mel
authors.initials: M
authors.lastname: Mupparapu
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000209:etiology*; D006801:Humans
chemical_list: D020533:Angiogenesis Inhibitors